Information

2014/09/29

Notice of Exercise Price of Stock Option etc

2014/09/12

Notice of Granting Stock Option to Board of Directors

2014/09/04

Tokyo Administrative Office Relocation

2014/09/01

Re-assignment of Industry Category

2014/07/01

F351 Phase II Clinical Trial Approval

2014/06/11

World Orphan Drug Congress Asia

2014/05/09

Patent Allowance for Etuary and F351 in the U.S.

2014/03/19

Notice for completion of the registration of incorporation of a subsidiary

2014/02/27

Notice of Changing of Accounting Auditor

2014/02/27

Announcement of the 13th Annual General Shareholder Meeting